cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Kala Pharmaceuticals Inc
43 own
59 watching
Current Price
$6.58
$-0.05
(-0.75%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
19.51M
52-Week High
52-Week High
18.20000
52-Week Low
52-Week Low
5.10000
Average Volume
Average Volume
0.01M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization19.51M
icon52-Week High18.20000
icon52-Week Low5.10000
iconAverage Volume0.01M
iconDividend Yield--
iconP/E Ratio--
What does the Kala Pharmaceuticals Inc do?
N/A
Read More
How much money does Kala Pharmaceuticals Inc make?
News & Events about Kala Pharmaceuticals Inc.
Globe Newswire
1 year ago
MENLO PARK, Calif. and ARLINGTON, Mass., April 28, 2023 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, today ...
Globe Newswire
1 year ago
ARLINGTON, Mass., April 12, 2023 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, today announced that the U.S. Food ...
Globe Newswire
1 year ago
--No safety issues identified in Cohort 1 ---- Now proceeding to Cohort 2 to evaluate the safety and efficacy of two doses of KPI-012 in a multicenter, randomized, double-masked, vehicle-controlled trial ---- Topline data for Cohort 2 targeted for 1Q 2024; if positive, trial could potentially serve ...
PR Newswire
1 year ago
Thinking about buying stock in BridgeBio Pharma, Kala Pharmaceuticals, Azul, Unicycive Therapeutics, or Ciena Corp? Thinking about buying stock in BridgeBio Pharma, Kala Pharmaceuticals, Azul, Unicycive Therapeutics, or Ciena Corp? PR Newswire NEW YORK, March 6, 2023 NEW YORK, March 6, 2023...
Globe Newswire
1 year ago
-- Enrolled first patient in CHASE Phase 2b clinical trial evaluating KPI-012 for PCED; Top-line data targeted for 1Q 2024 -- -- Closed $31.0 million private placement financing, extending cash runway into 1Q 2025 -- ARLINGTON, Mass., March 03, 2023 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (...
Frequently Asked Questions
Frequently Asked Questions
What is Kala Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Kala Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Kala Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Kala Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Kala Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Kala Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Kala Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Kala Pharmaceuticals Inc?
plus_minus_icon
What percentage is Kala Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Kala Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$6.58
$-0.05
(-0.75%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00